CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

BAJAJ HEALTHCARE LTD.

NSE : BAJAJHCAREBSE : 539872ISIN CODE : INE411U01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE322.550.65 (+0.2 %)
PREV CLOSE () 321.90
OPEN PRICE () 322.95
BID PRICE (QTY) 322.20 (5)
OFFER PRICE (QTY) 323.00 (100)
VOLUME 1074
TODAY'S LOW / HIGH ()322.55 325.90
52 WK LOW / HIGH ()272.45 516.2
NSE322.600.6 (+0.19 %)
PREV CLOSE() 322.00
OPEN PRICE () 324.00
BID PRICE (QTY) 322.65 (1)
OFFER PRICE (QTY) 323.05 (2)
VOLUME 38875
TODAY'S LOW / HIGH() 322.25 325.40
52 WK LOW / HIGH ()272.35 515.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Sajankumar Rameshwarlal Bajaj - Chairman Sajankumar Rameshwarlal Bajaj - Managing Director

Registered Office :

Address : 602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/ A, B-39 A/1, Road No. 23,Wagle Industrial Estate, Thane (West),
Thane Dist,
Maharashtra-401604

Phone : 022 6617400 / 401

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,L B S Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
13Aug Bajaj Healthcare gets DCGI approval to
Bajaj Healthcare has received approval from the Drugs Controller General..
13Aug Bajaj Healthcare jumps on getting DCGI
Bajaj Healthcare is currently trading at Rs. 334.90, up by 7.25 points o..
02May Bajaj Healthcare submits board meeting
Bajaj Healthcare has informed that the meeting of the Board of Directors..
19Mar Bajaj Healthcare informs about disclos
Bajaj Healthcare has informed that it enclosed disclosure under Regulati..
17Mar Bajaj Healthcare informs about disclo
Pursuant to Regulation 30 of Securities and Exchange Board of India (Lis..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit136.97157.65
Gross Profit 164.58 289.22
Operating Profit 295.631119.51
Net Sales 1656.326110.31
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Kwality Pharma (BSE)
 3464.80 (3.21%)
M.Cap ( in Cr)
3588.09
Bharat Parenterals (BSE)
 1475.00 (6.66%)
M.Cap ( in Cr)
1016.56
Acutaas Chemicals (BSE)
 3229.00 (1.91%)
M.Cap ( in Cr)
26428.82
Glenmark Pharma. (BSE)
 2350.25 (1.92%)
M.Cap ( in Cr)
66281.88
Glaxosmithkline Phar (BSE)
 2943.00 (1.50%)
M.Cap ( in Cr)
49974.78
Shareholding Pattern
PROMOTERS 58.59%
NON-INSTITUTION 37.3%
MUTUAL FUNDS/UTI 1.69%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
HDFC Pharma and Hea...1.42

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77282.33-258.50 (-0.33%)
NIFTY24175.80-76.20 (-0.31%)
Dow Jones 53277.01517.80 (0.98%)
Nasdaq 26180.46113.29 (0.43%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI